The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
Reviewed by Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila Konar, ...
What are some triggers that may be the cause of challenging behaviors in people with Alzheimer’s disease? A person with Alzheimer’s disease or other dementia most likely will experience significant ...
Over 6 million Americans are impacted by Alzheimer's disease, and researchers from Vanderbilt University Medical Center and the University of Pittsburgh are discovering how lifestyle habits can impact ...
A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of ...
Reviewed by Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila Konar, ...
Researchers at Georgia Tech have uncovered findings with implications for understanding memory and learning, which could lead to restoring memory in Alzheimer's patients. Researchers have uncovered ...
Arginine reduced Alzheimer's plaques and improved memory in mice, offering hope for future medical treatments.
Research reveals why Alzheimer’s brain damage doesn’t always lead to dementia, highlighting the role of protective brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results